天然产物研究与开发 ›› 2019, Vol. 31 ›› Issue (7): 1130-1137.doi: 10.16333/j.1001-6880.2019.7.003

所属专题: No.3

• 研究论文 • 上一篇    下一篇

基于网络药理学的杜仲-山茱萸配伍治疗糖尿病的作用机制

韩立柱1,胡坤霞1,巨红叶1,段玺2,唐志书1*,宋逍1*   

  1. 1陕西中医药大学药学院;2陕西中医药大学附属医院,咸阳712046
  • 出版日期:2019-07-29 发布日期:2019-07-29
  • 基金资助:

    陕西省中药基础与新药研究重点实验室项目(1008);陕西省中药制药重点学科专项(1008);国家中医药管理局中药制剂三级实验室项目(1008)

The mechanism of action of Eucommia ulmoides and Cornus officinalis in the treatment of diabetes mellitus based on network pharmacology

HAN Li-zhu1,HU Kun-xia1,JU Hong-ye1,DUAN Xi2,TANG Zhi-shu1*,SONG Xiao1*   

  1. 1School of Pharmacy,Shaanxi University of Chinese Medicine; 2Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712046,China
  • Online:2019-07-29 Published:2019-07-29

摘要: 为探讨杜仲-山茱萸治疗糖尿病的作用机制。研究利用网络药理学的方法,首先通过中药系统药理学数据库筛选出杜仲和山茱萸的活性成分和相关靶点,再利用DisGeNET、DrugBank等数据库筛选出糖尿病的潜在靶点。以STRING数据库对活性靶点构建蛋白互作网络(PPI)分析,采用Cytoscape 3.7.0 软件绘制其“成分-靶点-通路”的相互作用网络,通过CludterProfiler对靶蛋白进行生物过程、细胞组分及分子功能分析;京都基因与基因组(KEGG)的代谢通路分析。实验结果筛选得到杜仲-山茱萸有效成分30个,其中槲皮素、山奈酚、β-谷甾醇等成分对PTGS2、DPP4、ADRB2、PPARG等相关靶点通过IL-17信号通路、钙信号通路、脂肪细胞脂解的调控等参与氮化合物代谢过程、血液循环、脂肪细胞分化和血压调节等过程。综上,杜仲-山茱萸配伍治疗糖尿病存在多成分和多重药理作用机制,为进一步研究其治疗糖尿病药理实验提供了参考,也为其他中药的相关研究提供借鉴和参考。

关键词: 网络药理学, 杜仲, 山茱萸, 活性成分, 代谢通路

Abstract: In this study,the mechanism of Eucommia ulmoides and Cornus officinalis in the treatment of diabetes mellitus was studied by means of network pharmacology.Firstly,the active components and related targets of Eucommia ulmoides and Cornus officinalis  were screened out by traditional Chinese medicine systematic pharmacological database,and then the potential targets of diabetes mellitus were screened out by DisGeNET,DrugBank and other databases.The active target constructed protein interaction network (PPI) was analyzed by STRING database.The interaction network of "component,target and pathway" was drawn by Cytoscape 3.7.0 software,and the biological process of the target protein was carried out by CludterProfiler.Cell composition and molecular function analysis;Metabolic pathway analysis of Kyoto gene and genomic (KEGG).The results showed that 30 active components of Eucommia ulmoides and Cornus officinalis were screened,in which quercetin,kaempferol and β-sitosterol were used to target PTGS2,DPP4,ADRB2,PPARG through IL-17 signaling pathway and calcium signaling pathway.The regulation of adiposis is involved in nitrogen metabolism,blood circulation,adipocytes differentiation and blood pressure regulation.In summary,there are multiple components and multiple pharmacological mechanisms in the treatment of diabetes mellitus with the combination of Eucommia ulmoides and Cornus officinalis,which provides a reference for further study on the pharmacological experiment of the treatment of diabetes mellitus,and also provides a reference for the related research of other traditional Chinese medicine.

Key words: network pharmacology, Eucommia ulmoides Oliv., Cornus officinalis Sieb.et Zucc.;active components;metabolic pathway

中图分类号: 

R285.5